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In interventional cardiology (IC), patients may be exposed to high doses to the skin 
resulting in tissue reactions (skin burns) following single or multiple procedures. To 
address this issue, online and offline software has been developed to estimate the 
maximum skin dose (MSD) to the patient from IC procedures. However, the capabilities 
and accuracy of such skin dose calculation (SDC) software to estimate MSD and 2D 
dose distributions markedly differ among vendors. Hence, this project focuses on the 
harmonisation of RDSR (radiation dose structured report) and on the validation of SDC 
software products in IC, which will optimise radiation protection of patients. The 
outcome of the project will include the standards for digital dose reporting, 
development of protocols for acceptance testing and Quality Control (QC) of SDC 
software and setting of diagnostic reference levels per clinical complexity, assessing the 
frequency of high-dose procedures as well as dose reduction strategies based on the 
multi-centric data collection. This paper focuses on the work performed to investigate 
performance of solid state dosimeters used in clinical environment. 
 





Fluoroscopically guided interventional procedures in interventional radiology (IR) and 
cardiology (IC) are techniques that have had increased use in the last decades. 
Although, they reduce most of the risks to patients, prolonged exposures due to 
complicated interventional procedures or use of inappropriate equipment may result in 
high doses to both patients and staff members, in particular, with potentially high 
radiation doses to the patient‘s skin. Numerous cases of radiation-induced deterministic 
tissue reactions following exposure in interventional procedures, such as erythema and 
hair loss, have been reported in the literature [1-3]. Recommendations for operators 
performing interventional procedures were published a few decades ago and the need 
for measuring patient dose was expressed [4]. Since then, a huge effort has been made 
to identify practical and easy-to-use methods to monitor and reduce patient skin doses in 
interventional procedures [2-3]. The steady increase in the number of IC procedures 
over the years has further strengthened that need.  
 
2. Assessment of skin dose in interventional procedures 
Until recently, measurements using passive dosimeters were the only way to assess 
patient‘s maximum skin dose (MSD) accurately. However, as these measurements are 
tedious and expensive to undertake, they could not be performed routinely at clinics and 
a more convenient means to estimate MSD was needed. Automated online and offline 
skin dose calculation (SDC) solutions have therefore been developed. Online software 
tools utilise live data streaming from the angiographic system to calculate skin doses 
directly during intervention, while offline solutions use data stored in the radiation dose 
structured report (RDSR) to compute skin exposure after the procedure. Currently, most 
vendors have implemented some form of skin dose calculations in their angiographic 
systems: from simple solutions only computing maximum cumulative air kerma doe 
specific angulations, values, to more advanced software solutions calculating a 2D 
distribution of the skin dose. Offline SDC software solutions have also been developed 
in research-based institutions or for commercial purposes, both as stand-alone products 
or integrated into the dose archiving and communication systems of the hospital. 
However, the capabilities and accuracy of such SDC software to estimate MSD and 2D 
dose distributions markedly differ among vendors; and the reporting of the MSD 
estimate and the related accuracy in the RDSR is neither systematic nor harmonised. In 
addition, there is currently no acceptance testing and quality control (QC) protocols of 
such systems. 
 
3. VERIDIC project: accuracy of skin dose calculation software in interventional 
cardiology 
Hence, the VERIDIC project (Validation and Estimation of Radiation skIn Dose in 
Interventional Cardiology), funded under European Joint Programme for the Integration 
of Radiation Protection Research, H2020 (Grant agreement No 662287), focuses on the 
harmonisation of RDSR and on the validation of SDC software products in IC, which 
will optimise radiation protection of patients. The project involves 10 partners from 8 
European countries. It started on the 1 February 2018 and will run for 2 years. The aims, 
methodology and some of the preliminary results of the VERIDIC project are presented 




in this work.  The project is divided in three work packages (WP), while  specific 
aims of  each WP  can be summarized as:  
 Standards for digital dose reporting: 1) A complete list of parameters necessary 
to calculate MSD and 2D dose distribution (tube voltage, filtration, beam 
orientation, table position, backscatter factor, table attenuation, air 
KERMA-to-skin dose conversion coefficient, etc.); 2) The recording (format and 
content) of MSD values and 2D dose distributions in the RDSR. 
 Protocols for acceptance testing and QC of SDC software, including: 1) 
comprehensive calibration of field dosimeters to be used for software 
benchmarking, including estimation of associated uncertainty; 2) acceptance 
testing of online and offline software in simple irradiation conditions; 3) QC 
tests of the software in clinical settings reproducing complex cardiac procedures 
such as Chronic Total Occlusions (CTO). 
 Interventional Diagnostic Reference Levels (DRL) and frequency of high-dose 
procedures as well as dose reduction strategies will be established thanks to a 
multi-centric data collection.  
 
4. Methodology of the VERIDIC project 
WP1. Standards for digital dose reporting: SDC software solutions are analysed 
according to their calculation algorithms and their capabilities. In particular, the factors 
considered in the calculation of the MSD estimates (such as the backscatter, the table 
attenuation or the patient‘s body shape) and how they are reported by different 
manufacturers are investigated. The availability of the parameters mandatory for MSD 
estimate are evaluated within a sample of RSDR collected in the participating hospitals. 
Furthermore, recommendations for harmonisation of the MSD reporting among 
different systems will be formulated.  
WP2. Protocols for acceptance testing and QC of SDC software: Most commonly used 
field dosimeters, Gafchromic films and thermoluminescent dosimeters (TLDs) and 
semiconductor dosemeters (multimeters), are characterised and calibrated for a wide 
range of conditions encountered in IC, leading to a precisely computed uncertainty. 
Protocols for acceptance and QC tests to be used by medical physicists in clinical 
practice will be developed. Those protocols will also enable the comparison of different 
SDC software. Tolerance levels and technical criteria for acceptance of SDC systems 
will be proposed. Techniques and existing equipment, such as phantoms and 
dosimeters, readily accessible to medical physicists in clinical environment will be 
favoured in the QC approach. The QC and acceptance protocols will be first tested on 
angiographic systems equipped with existing, online SDC software. The RDSR of these 
experiments will be extracted from the angiographic systems and input in available 
offline SDC software for skin dose calculations. Calculated results will be compared 
with reference measurements. Exposure parameters of high-dose procedures will be 
extracted from the RDSR collected in several European hospitals (see below). Those 
procedures will be repeated on a Rando-Alderson phantom and measured using TLDs 
and Gafchromic films. The results will be used for comparison of reference dose 
measurements with dose estimates using online and offline SDC in realistic clinical 
conditions.  
WP 3. Interventional Reference Levels and dose reduction strategies: In at least 12 
European hospitals, 19 angiographic units with RDSR/dose reports , the project partners 




will collect at least 50 cardiac therapeutic procedures per centre with RDSR and clinical 
indications, in order to develop reference levels. Skin dose will be calculated on 
different SDC software solutions depending on the availability of RDSR. Statistical 
analysis will be performed to find correlation between clinical parameters (procedure as 
well as clinical parameters) and patient exposure on one side as well as technical 
parameters (from RDSR) and patient exposure on another side. Reference levels will be 
developed based on clinical complexity. Moreover, the frequency of high dose 
procedures will be assessed and recommendations for patient dose optimization will be 
derived. 
 
5. Characterisation of the solid-state multimeters used in clinical practice 
One of the tasks under WP2. Protocols for acceptance testing and QC of SDC software 
Task 2.1, is related to the calibration of field dosimeters and traceability to a national 
standard. Various examination techniques are employed in diagnostic radiology using 
tube voltages from approximately 20 kV to 150 kV. An accurate measurement of dose 
requires correct calibration of the instrumentation in radiation fields of known 
properties. In diagnostic radiology, the specification of radiation qualities is important 
as the response of all dosimeters depends, at least to a certain extent, on the spectral 
distribution of the X- rays employed. Ionization chambers have been the standard 
instruments used for diagnostic radiology dosimetry and quality assurance assessments 
for many years. Dosemeters based on semiconductor technology are now becoming 
widely available, and as the semiconductor detectors are smaller they are more 
convenient to use in many situations. Diagnostic dosemeters should be designed in 
compliance with IEC 61674 standard [5], which applies both to dosimeters equipped 
with ionization chambers and to semiconductor detectors. Traditionally, the main 
disadvantage of these devices has been their energy dependence of response which 
differs considerably from that of ionization chambers. Semiconductor diodes do not 
have the inherent relatively constant response with photon energy in the diagnostic 
X-ray range for measurement of air kerma that is a feature of ion chambers. Multiple 
semiconductor elements are incorporated into the semiconductor detector used for X-ray 
dosimetry. in order to make an assessment of radiation quality that is used to derive a 
dose compensation which is applied automatically. The angular dependence of 
measurements made using semiconductors is different from that of ionisation chambers. 
The commercial semiconducting detectors are mounted on lead backing plates, to 
attenuate radiation incident from the rear. This is required to ensure that the radiation 
incident on the detector elements represents that transmitted through filters at the front 
of the detector i.e.to ensure that the automatic energy compensation is applied correctly. 
As a result, it is the air kerma incident from the direction of the primary beam that is 
measured.  Nevertheless, these types of detectors have found many applications in 
routine clinical measurements in hospitals. Most of them are capable of determining the 
air kerma, tube voltage, half value layer (HVL), and exposure time, as well as the output 
waveform from a single irradiation.  
The dosemeters are routinely calibrated at the following standard radiation qualities 
(reference beam qualities according to IEC 61267): RQR 3 (50 kV) - RQR 5 (70 kV) - 
RQR 6 (80 kV) - RQR 8 (100kV) - RQR 9 (120 kV) which are not necessarily 
representative of the settings used clinically. The performance testing of X-ray 
equipment often requires the assessment of doses and dose rates for X-ray beams with 




many different radiation qualities and in non-standard conditions. The combination of 
different energy and angular responses will influence detector performances in different 
X-ray fields, and could lead to significant differences in air kerma measurements. If 
different dosemeters are used for QC assessments, users must understand what is being 
recorded and how the measurements are influenced by the detector characteristics.  
 
Table 1. Solid state dosemeters tested in different standard and non-standard beam 
qualities. 
 
No Manufacturer Model X-ray tube voltage 
or energy 
Dose range Dose rate range 




35 – 155 kV 15 nGy – 1000 Gy 15 nGy/s – 
450 mGy/s 




Not specified 2 nGy – 10 kGy 0.04 µGy/s – 
160 mGy/s 




50–150 kVp, 1–90 
mm Al or 2 mm Cu 
0.1 nGy–1500 Gy 1 nGy/s–320mGy/s 
 
4 RaySafe, RTI, 
Moldaln, 
Sweden 
Xi R/F  
Classic 
35 – 160 kV/kVp 
(for up to 0.5 mm Cu 
or equivalent) 






Figure 1. Energy response of four different solid -state dosimeters. 
 
Therefore, the performance of four different semiconducor dosemeters/multimeters 
(Table 1) was investigated, both in standard and non-standard conditions. Tested 
parameters evaluated during characterisation of the solid-state dosemeters were: in air 
comparison, angular response, in air comparison for energy response and response 
linearity. The X –ray beams were generated using an X-ray unit Hopewell Design, with 
X-ray tube voltage (10-225) kV, whereas the dosimetry standard was an ionization 
chamber Exradin A3 with reference class electrometer Unidos (PTW, Germany). 
 






Figure 2. Linearity of four different solid -state dosimeters. 
 
 




Figure 3. Angular response of four different solid -state dosimeters. 
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Interventne procedure u radiologiji i kardiologiji povezani sus a visokim dozama za 
koţu pacijenta i potencijalnim radijacionim povredama koţe. Razliţita metodologije i 
rešenja razvijene us za procenu maksimalne doze za koţu, ţija se svojsvta, ukljuţujuši i 
taţnost znaţajno razlikuju. U radu su prokazani ciljevi, metode i preminiran a rešenja 
projekta VERIDIC usmerenoj na validaciju zaliţitih ofline i online softvera za procenu 
doze za koţu pacijenta u intervenatnoj kardiologiji. 
 
